Benitec Biopharma Inc. (BNTC)

NASDAQ

$8.61

$-0.46

(-5.07%)

Pre-Market

Benitec Biopharma Inc. (BNTC) Live Price Chart

Last updated: ⁦2026-10-14 12:37:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Benitec Biopharma Inc. (BNTC) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $8.61, with a market capitalisation of $316.39M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $8.51 to $16.76. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$316.39M
Open	$9.08
Day's High	$295.62
Day's Low	$1.86
Previous Close	$9.07
Volume	132.05K
Average Volume	159.43K
P/E Ratio	--
52-Week High	$16.76
52-Week Low	$8.51
Dividend Yield	--
Earnings Date	--

Benitec Biopharma Inc. (BNTC) Pre-Market Stock Price

Benitec Biopharma Inc. (BNTC) is trading at $9.08 in pre-market trading as of 2026-10-13 23:31:00, up 0.06% ($0.00) from the previous close of $9.07

Pre-market trading shows how investors are pricing BNTC before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.

Benitec Biopharma Inc. (BNTC) 7-Day Stock Price Change

Over the past seven days, Benitec Biopharma Inc. (BNTC) moved from $9.23 to $8.61, representing a decline of 6.67% ($0.62).

The stock traded between $8.51 and $9.99 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 235.97 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

BNTC 52-Week Price Position

Position in Range: 1.3%

52W Low$8.51

52W High$16.76

BNTC is currently trading at $8.61, placing it 1.3% of the way from its 52-week low of $8.51 to its 52-week high of $16.76. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Benitec Biopharma Inc. (BNTC)?

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.

Benitec Biopharma Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	24
Exchange	NASDAQ
Company Website	https://www.benitec.com

How to Buy Benitec Biopharma Inc. (BNTC) Stock on MEXC

Eligible investors can buy real shares of Benitec Biopharma Inc. (BNTC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for BNTC and Place Your Order

Open the RealStocks trading page and search for BNTC. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Benitec Biopharma Inc. (BNTC) stock price today?

Benitec Biopharma Inc. (BNTC) is currently trading at $ 8.61, down 5.03% ($0.46) from the previous close of $ 9.07. Intraday prices update in real time during regular trading hours.

2.Is BNTC stock going up or down today?

As of 2026-10-13 23:31:00, BNTC is trading at $ 8.61, down 5.03% ($0.46) from its previous close of $ 9.07. The stock has traded between $ 1.86 and $ 295.62 during today’s regular session. Past price movements do not guarantee future results.

3.What is BNTC pre-market price?

As of 2026-10-13 23:31:00, BNTC is trading at $ 9.08 in pre-market trading, up 0.06% ($0.00) from the previous close of $ 9.07. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is BNTC after-hours price?

As of 2026-10-13 23:31:00, BNTC is trading at $ 8.64 in after-hours trading, down 4.74% ($0.43) from the regular-session close of $ 9.07. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is BNTC stock trading now?

BNTC trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does BNTC sit relative to its 52-week high and low?

Over the past 52 weeks, BNTC has traded between a low of $ 8.51 and a high of $ 16.76. At $ 8.61, the stock is positioned 1.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Benitec Biopharma Inc. in?

Benitec Biopharma Inc. (BNTC) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Benitec Biopharma Inc.'s market capitalisation and where is it listed?

Benitec Biopharma Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 316.39M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is BNTC valued in terms of P/E ratio and EPS?

BNTC trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.31. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Benitec Biopharma Inc. pay a dividend?

Benitec Biopharma Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.